Literature DB >> 20505343

Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.

Jihong Chen1, Feras M Ghazawi, Qiao Li.   

Abstract

The bromodomain is an evolutionarily conserved motif found in many transcriptional activators including p300 which contains an intrinsic histone acetyltransferase activity and is a general coactivator for many transcription factors. One mode of bromodomain action is to serve as a binding module to recognize specific acetyl-lysine residue of histones during chromatin remodeling and transcriptional activation. The function of p300 is required for diverse sets of gene expression. However, it is not known whether the p300 bromodomain is involved in the expression of all or only subset of p300-dependent genes. In this study, we examined the impact of either wild type or a bromo-deficient p300 on the expression of several p300-dependant genes. The effects of histone acetylation on the expression of these genes were also assessed by targeting histone deacetylase activities with an inhibitor approach. We show that the impact of these inhibitors on the transcriptional activation of p300-dependent genes are impaired in cells containing the bromo-deficient p300, indicating that the interplay of p300 and histone acetylation in p300-dependent gene transcription requires the bromodomain. We also observed an increase in the expression of bromo-deficient p300 at the level of transcription possibly to compensate for the loss of p300 function. However, the high level of bromo-deficient p300 is not able to maintain the basal level of histone acetylation. Thus, the bromodomain is important for p300 to maintain the basal level of histone acetylation and to induce the transcriptional activation of p300-dependent genes. Nevertheless, the requirement of bromodomain and histone acetylation in p300-dependent gene transcription is determined by a gene specific manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505343      PMCID: PMC3322497          DOI: 10.4161/epi.5.6.12224

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  45 in total

1.  The Gcn5 bromodomain co-ordinates nucleosome remodelling.

Authors:  P Syntichaki; I Topalidou; G Thireos
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

2.  Structure and function of a human TAFII250 double bromodomain module.

Authors:  R H Jacobson; A G Ladurner; D S King; R Tjian
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

Review 3.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

4.  Mutations truncating the EP300 acetylase in human cancers.

Authors:  S A Gayther; S J Batley; L Linger; A Bannister; K Thorpe; S F Chin; Y Daigo; P Russell; A Wilson; H M Sowter; J D Delhanty; B A Ponder; T Kouzarides; C Caldas
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

5.  Ubiquitin-dependent distribution of the transcriptional coactivator p300 in cytoplasmic inclusion bodies.

Authors:  Jihong Chen; Sabina Halappanavar; John P H Th' ng; Qiao Li
Journal:  Epigenetics       Date:  2007-04-23       Impact factor: 4.528

6.  Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.

Authors:  W L Kraus; E T Manning; J T Kadonaga
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 7.  Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.

Authors:  Ailsa J Frew; Ricky W Johnstone; Jessica E Bolden
Journal:  Cancer Lett       Date:  2009-04-08       Impact factor: 8.679

8.  Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway.

Authors:  Jonathan R St-Germain; Jihong Chen; Qiao Li
Journal:  Epigenetics       Date:  2008-11-15       Impact factor: 4.528

9.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.

Authors:  F Petrij; R H Giles; H G Dauwerse; J J Saris; R C Hennekam; M Masuno; N Tommerup; G J van Ommen; R H Goodman; D J Peters
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

10.  Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B.

Authors:  Jihong Chen; Feras M Ghazawi; Wafae Bakkar; Qiao Li
Journal:  Mol Cancer       Date:  2006-12-11       Impact factor: 27.401

View more
  18 in total

1.  Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.

Authors:  Srimoyee Ghosh; Alexander Taylor; Melissa Chin; Hon-Ren Huang; Andrew R Conery; Jennifer A Mertz; Andres Salmeron; Pranal J Dakle; Deanna Mele; Alexandre Cote; Hari Jayaram; Jeremy W Setser; Florence Poy; Georgia Hatzivassiliou; Denise DeAlmeida-Nagata; Peter Sandy; Charlie Hatton; F Anthony Romero; Eugene Chiang; Thornik Reimer; Terry Crawford; Eneida Pardo; Venita G Watson; Vickie Tsui; Andrea G Cochran; Laura Zawadzke; Jean-Christophe Harmange; James E Audia; Barbara M Bryant; Richard T Cummings; Steven R Magnuson; Jane L Grogan; Steve F Bellon; Brian K Albrecht; Robert J Sims; Jose M Lora
Journal:  J Biol Chem       Date:  2016-04-07       Impact factor: 5.157

Review 2.  Epigenetics and bacterial infections.

Authors:  Hélène Bierne; Mélanie Hamon; Pascale Cossart
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

3.  Polyamine-based small molecule epigenetic modulators.

Authors:  Shiv K Sharma; Stuart Hazeldine; Michael L Crowley; Allison Hanson; Ross Beattie; Sheeba Varghese; Thulani M D Senanayake; Aiko Hirata; Fusao Hirata; Yi Huang; Yu Wu; Nora Steinbergs; Tracey Murray-Stewart; Ian Bytheway; Robert A Casero; Patrick M Woster
Journal:  Medchemcomm       Date:  2011-11-26       Impact factor: 3.597

4.  Landscape of genomic alterations in cervical carcinomas.

Authors:  Akinyemi I Ojesina; Lee Lichtenstein; Samuel S Freeman; Chandra Sekhar Pedamallu; Ivan Imaz-Rosshandler; Trevor J Pugh; Andrew D Cherniack; Lauren Ambrogio; Kristian Cibulskis; Bjørn Bertelsen; Sandra Romero-Cordoba; Victor Treviño; Karla Vazquez-Santillan; Alberto Salido Guadarrama; Alexi A Wright; Mara W Rosenberg; Fujiko Duke; Bethany Kaplan; Rui Wang; Elizabeth Nickerson; Heather M Walline; Michael S Lawrence; Chip Stewart; Scott L Carter; Aaron McKenna; Iram P Rodriguez-Sanchez; Magali Espinosa-Castilla; Kathrine Woie; Line Bjorge; Elisabeth Wik; Mari K Halle; Erling A Hoivik; Camilla Krakstad; Nayeli Belem Gabiño; Gabriela Sofia Gómez-Macías; Lezmes D Valdez-Chapa; María Lourdes Garza-Rodríguez; German Maytorena; Jorge Vazquez; Carlos Rodea; Adrian Cravioto; Maria L Cortes; Heidi Greulich; Christopher P Crum; Donna S Neuberg; Alfredo Hidalgo-Miranda; Claudia Rangel Escareno; Lars A Akslen; Thomas E Carey; Olav K Vintermyr; Stacey B Gabriel; Hugo A Barrera-Saldaña; Jorge Melendez-Zajgla; Gad Getz; Helga B Salvesen; Matthew Meyerson
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

Review 5.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

Review 6.  Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.

Authors:  Feng Wang; Christopher B Marshall; Mitsuhiko Ikura
Journal:  Cell Mol Life Sci       Date:  2013-01-11       Impact factor: 9.261

Review 7.  Design of small molecule epigenetic modulators.

Authors:  Boobalan Pachaiyappan; Patrick M Woster
Journal:  Bioorg Med Chem Lett       Date:  2013-11-13       Impact factor: 2.823

8.  Contribution of retinoid X receptor signaling to the specification of skeletal muscle lineage.

Authors:  Melanie Le May; Hymn Mach; Natascha Lacroix; Chenchen Hou; Jihong Chen; Qiao Li
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

9.  Molecular Basis for the Regulation of Transcriptional Coactivator p300 in Myogenic Differentiation.

Authors:  Jihong Chen; Yingjian Wang; Munerah Hamed; Natascha Lacroix; Qiao Li
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

10.  Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins.

Authors:  Junlin Li; Guifang Zhao; Xiaocai Gao
Journal:  J Neurodev Disord       Date:  2013-02-20       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.